|
|||||
|
|
Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis |
|
| Authors: | Luis Paz-Ares Denis Soulières Ivan Melezínek Joachim Moecks Lorenz Keil Tony Mok Rafael Rosell Barbara Klughammer |
| Institution: | Hospital Universitario Virgen del Rocío, Seville, Spain;Centre Hospitalier de l'Universitéde Montréal, Montréal, Canada;Roche Products Ltd, Welwyn Garden City, UK;BIOMCON GmbH, Mannheim, Germany;Roche Diagnostics GmbH, Penzberg, Germany;Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China;Catalan Institute of Oncology, Barcelona, Spain;F. Hoffmann-La Roche Ltd., Basel, Switzerland |
| Abstract: | |
| Keywords: | adenocarcinoma chemotherapy epidermal growth factor receptor erlotinib gefitinib lung cancer mutation tyrosine kinase inhibitor |